Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma

Area of Science:

• Pediatric Oncology
• Rare Cancers
• Clinical Trials

Background:

• Rhabdomyosarcoma (RMS) predominantly affects children and adolescents.
• A small subset of RMS cases occur in infants under one year of age.
• Infant RMS studies yield varied results due to rarity and differing treatment protocols.

Purpose of the Study:

• To review outcomes for infants with RMS treated in clinical trials.
• To discuss strategies used by international groups to reduce treatment-related morbidity and mortality.
• To explore novel diagnostic and management approaches for infant RMS.

Main Methods:

• Review of outcomes from infant RMS clinical trials.
• Analysis of treatment strategies from international cooperative groups.
• Discussion of unique RMS subtypes: congenital/neonatal, spindle cell, and relapsed.

Main Results:

• Heterogeneous results reported in existing literature due to small sample sizes and varied approaches.
• International cooperative groups are actively developing strategies to improve infant RMS care.
• Novel approaches are under investigation to enhance diagnosis and management.

Conclusions:

• Infant RMS requires specialized approaches due to its rarity and unique clinical scenarios.
• Reducing treatment toxicity without compromising survival is a key focus.
• Ongoing research into novel diagnostic and therapeutic strategies holds promise for improving outcomes.